Nora Katabi | Pathology | Best Researcher Award

Published on by Global Academic Awards

Dr. Nora Katabi | Pathology | Best Researcher Award

Dr. Nora Katabi, Memorial Sloan Kettering Cancer Center, United States

Dr. Nora Katabi is a distinguished Associate Member and Attending Pathologist at Memorial Hospital for Cancer and Allied Diseases (MSKCC), with a specialization in oncologic surgical pathology. She earned her M.D. from Damascus University in 1997 and completed her residency in Anatomic and Clinical Pathology at Baylor University Medical Center, followed by a prestigious fellowship at MSKCC. Her research focuses on histopathologic and molecular characterization of salivary gland tumors and head and neck squamous cell carcinoma, with multiple funded projects and IRB-approved studies. As Principal Investigator, she has led groundbreaking studies on NR4A3 abnormalities and polymorphous adenocarcinomas. A committed educator, she has served as Associate Program Director of the surgical pathology fellowship since 2017. Dr. Katabi is an editorial board member for Head and Neck Pathology and Cancers, and an active contributor to global pathology standards. Her leadership and scholarship make her a leading figure in diagnostic and translational pathology.

Publication Profile

Scopus

Educational and Postdoctoral Training Background

Dr. Nora Katabi earned her M.D. from the Damascus University School of Medicine, Syria, in 1997, laying the foundation for her distinguished career in pathology. She pursued several externships to broaden her clinical exposure and research skills, including cardiovascular training at Brigham and Women’s Hospital, Harvard University (1997–1998), and cancer cytogenetics at Wayne State University, Detroit (1998–1999). Further training in internal medicine and ambulatory cardiology was completed at Detroit Medical Center (1999–2000). Dr. Katabi began her residency in Anatomic and Clinical Pathology at Baylor University Medical Center in Dallas, Texas (2000–2005), where she also served as Chief Resident during her final year. She went on to complete a highly specialized fellowship in Oncologic Surgical Pathology at the Memorial Sloan-Kettering Cancer Center in New York (2005–2006). This rigorous academic and clinical trajectory equipped Dr. Katabi with a robust foundation for her impactful contributions in oncologic pathology and academic medicine.

Professional Positions and Employment

Dr. Nora Katabi has held a series of progressive academic and clinical positions at the Memorial Hospital for Cancer and Allied Diseases. She began her tenure as Instructor and Chief Fellow from July 2006 to June 2008, followed by a continued appointment as Instructor until June 2008. Dr. Katabi was then appointed Assistant Member (Level 1) from July 2008 to October 2011, before being promoted to Assistant Member, a role she held until December 2016. Since then, she has served as an Associate Member, a position she currently maintains. In parallel with her academic appointments, Dr. Katabi has also served in critical clinical roles. She was appointed Assistant Attending Pathologist (Level 1) from July 2008 to October 2011, then Assistant Attending Pathologist until December 2016. Currently, she holds the title of Associate Attending Pathologist, a role she has served in since December 2016, reflecting her expertise and leadership in oncologic surgical pathology.

Licensure and Board Certification

Dr. Nora Katabi is a board-certified pathologist with licensure to practice medicine in multiple states. She obtained her New York medical license (License No. 236757) on June 29, 2005, which remained valid through December 29, 2022. Additionally, she secured a medical license in New Jersey (License No. 25MA11182900) issued on July 7, 2021, with an expiration date of June 30, 2023. Dr. Katabi also holds a National Provider Identifier (NPI) number 107354826. Her professional credentials are further solidified through board certification by the American Board of Pathology in Anatomic and Clinical Pathology. She was officially certified on August 11, 2005, under Certificate No. 05-177. This certification reflects her comprehensive training, dedication to pathology, and adherence to the highest standards of clinical practice in diagnostic medicine. Dr. Katabi’s licensure and board status underscore her qualifications and longstanding commitment to excellence in medical pathology.

Research Focus

Dr. Nora Katabi’s research is primarily focused on head and neck pathology, with a particular emphasis on salivary gland tumors. Her work spans a comprehensive spectrum of low- to high-grade neoplasms, exploring their histologic, molecular, and clinicopathologic features. She has investigated the incidence and outcomes of nodal metastasis in low-grade salivary gland carcinomas, the diagnostic implications of molecular profiling in polymorphous adenocarcinomas, and the aggressive behavior of adenoid cystic carcinomas. Dr. Katabi’s contributions include evaluating tumor grading systems, identifying novel gene fusions in challenging carcinomas, and applying immunohistochemistry in the differential diagnosis of oncocytic and Warthin-like tumors. Her research integrates translational approaches, including RNA sequencing and morphologic analyses, to improve diagnostic accuracy and therapeutic strategies. Additionally, she has explored the prognostic factors in epithelial-myoepithelial carcinoma and examined active surveillance in pleomorphic adenomas. Collectively, her work advances understanding of rare head and neck malignancies, emphasizing precision diagnostics and improved patient management.

Publication Top Notes

  • “Nodal Metastasis in Low Grade Salivary Gland Carcinoma” – Head and Neck Pathology, 2025 | 📅 2025

  • “Comprehensive Evaluation of Polymorphous Adenocarcinoma with 2-Tiered Grading” – Modern Pathology, 2025 | 📅 2025

  • “Sympathetic Axonogenesis Promotes Adenoid Cystic Carcinoma Progression” – Journal of Experimental Medicine, 2025 | 📅 2025

  • “Long-Term Results of EBRT ± Chemotherapy in Differentiated Thyroid Cancer” – Thyroid, 2025 | 📅 2025

  • “Targeted RNA Sequencing in Head and Neck Carcinomas” – Histopathology, 2025 | 📅 2025 | 📑 1 citation | 🧬📊

  • “Active Surveillance for Pleomorphic Adenomas of the Parotid” – Journal of Surgical Oncology, 2025 | 📅 2025

  • “Histologic Predictors in Epithelial-Myoepithelial Carcinoma (EMC)” – Virchows Archiv, 2025 | 📅 2025

  • “Adjuvant Chemoradiotherapy for Oral Cavity SCC” – JAMA Otolaryngology, 2025 | 📅 2025

  • “Phase 2 Trial of Regorafenib in Recurrent Adenoid Cystic Carcinoma” – Clinical Cancer Research, 2024 | 📅 2024

  • “BSND Immunohistochemistry in Mucoepidermoid Carcinoma Diagnosis” – Head and Neck Pathology, 2024 | 📅 2024 | 📑 1 citation | 🧫🔬

 

Hollis Potter | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Hollis Potter | Medicine | Best Researcher Award

Dr. Hollis Potter, Hospital for Special Surgery, United States

Dr. Hollis Potter is an internationally recognized expert in musculoskeletal radiology with a distinguished career spanning over three decades. She earned her A.B. magna cum laude from Smith College and her M.D. from New York Medical College. After completing her residency at North Shore University Hospital, she pursued specialized fellowships in skeletal and musculoskeletal radiology at the Hospital for Special Surgery (HSS) and New York Hospital. Currently, she serves as Chairman of the Department of Radiology & Imaging at HSS and Professor of Radiology at Weill Cornell Medical College. Dr. Potter has held numerous leadership roles, including Director of Research and Chief of MRI, and has contributed extensively to NIH study sections and FDA advisory panels. Her work has earned her numerous honors, such as the Cabaud and Charles L. Christian Awards. A prolific scholar and editor, she is a driving force in imaging advancements for orthopaedic disorders and cartilage research worldwide.

Publication Profile

Google Scholar

Educational Background

Dr. Hollis Potter’s educational journey reflects academic excellence and an early commitment to medical sciences. She earned her A.B. degree magna cum laude from Smith College between 1976 and 1980, demonstrating exceptional scholastic achievement. During her undergraduate studies, she also participated in a prestigious junior year exchange program at Dartmouth College in Hanover, New Hampshire (1978–1979), enriching her academic experience at one of the Ivy League institutions. Following this, she pursued a medical degree (M.D.) at the New York Medical College from 1981 to 1985, laying the foundation for her career in radiology and musculoskeletal imaging. Her educational path not only showcases a solid grounding in liberal arts and medicine but also indicates her early exposure to multidisciplinary learning and elite academic environments. These formative years prepared Dr. Potter for a dynamic and impactful professional journey in the fields of diagnostic radiology, orthopaedics, and advanced MRI research.

Professional Positions and Employment

Dr. Hollis Potter has held a distinguished array of professional positions across top-tier medical institutions, showcasing her expertise in radiology and musculoskeletal imaging. She began her post-doctoral training with an internal medicine internship at Danbury Hospital (1985–1986), followed by a residency and Chief Residency in Diagnostic Radiology at North Shore University Hospital (1986–1990). She completed fellowships in Musculoskeletal and Skeletal Radiology at the Hospital for Special Surgery and Cornell University Medical College (1990–1991). Her academic roles include Assistant Professor at Cornell (1991–1998), Associate Professor (1998–2002), and currently Professor of Radiology at Weill Medical College of Cornell University. At the Hospital for Special Surgery, she progressed from Junior to Attending Radiologist and has served as Chief of the MRI Division since 1994, Director of Research (2000–2016), and Chairman of Radiology & Imaging since 2013. Her leadership and long-standing appointments reflect sustained excellence and innovation in imaging science.

Honors and Awards

Dr. Hollis Potter has received an impressive array of prestigious honors and awards throughout her illustrious career in musculoskeletal radiology and imaging research. Her early academic excellence was recognized with Phi Beta Kappa in 1980 and Alpha Omega Alpha in 1985. She has been a consistent recipient of high-level research awards, including the American Orthopaedic Association Research Award (1994), multiple Philip D. Wilson Awards for Excellence in Orthopaedic Surgery, and the Cabaud Award for Excellence in Basic Science (2005). Dr. Potter has delivered numerous keynote lectures at major conferences worldwide, such as the RSNA, ISMRM, and Knee Society. She earned the Gold Medal from the International Society of Magnetic Resonance in Medicine (2022) and the HSS Lifetime Achievement Award (2024). Her teaching excellence has been recognized with Outstanding Teacher Awards, and she has repeatedly appeared in New York Magazine’s Best Doctors list from 2003 to 2024, reflecting her long-standing impact in both clinical and academic spheres.

Research Focus

Dr. Hollis Potter’s research focus lies predominantly in Musculoskeletal (MSK) Radiology, with specialized expertise in magnetic resonance imaging (MRI) for the evaluation, diagnosis, and management of articular cartilage lesions, ligament injuries, joint degeneration, and orthopaedic implant complications. Her work extensively explores advanced MRI techniques, including T2 mapping, MAVRIC-SEMAC imaging, and quantitative assessments to monitor cartilage integrity, osteoarthritis progression, and soft tissue pathology post-surgery or injury. She has contributed significantly to understanding ACL injuries, osteochondral defects, rotator cuff healing, and periprosthetic tissue changes, often integrating clinical, surgical, and histopathological correlations. Many of her highly cited studies—such as those on microfracture techniques, cartilage repair with marrow aspirate, and post-arthroplasty imaging—reflect her impact in translational musculoskeletal imaging research. Her interdisciplinary approach links orthopaedics, sports medicine, and radiology, driving innovations that enhance both diagnostic precision and clinical decision-making in musculoskeletal healthcare.

Publication Top Notes

  • The microfracture technique for the treatment of articular cartilage lesions in the knee 🔢 1003 | 📅 2005

  • MRI of articular cartilage in the knee using fast-spin-echo imaging 🔢 801 | 📅 1998

  • Deep neural network improves fracture detection by clinicians 🔢 647 | 📅 2018

  • Bone marrow aspirate improves cartilage repair in equine model 🔢 532 | 📅 2010

  • Cellular and molecular biology of periprosthetic osteolysis 🔢 464 | 📅 2007 🦿🔍

  • Lateral epicondylitis: MRI, surgical, histopathologic findings 🔢 393 | 📅 1995

  • MRI of tibial plateau fractures and soft tissue injury 🔢 390 | 📅 2005

  • MRI findings of subscapularis tendon tears 🔢 360 | 📅 1997 🩻

  • MRI of the hip: labral and chondral abnormalities 🔢 358 | 📅 2005

  • Posterior tibial tendon insufficiency: ligament involvement 🔢 351 | 📅 2005

  • Rotator cuff healing with osteoinductive growth factors 🔢 340 | 📅 2007

  • Cartilage injury after ACL tear: clinical/MRI follow-up 🔢 332 | 📅 2012

  • IL-15 in knee OA: cytokine profiles in early vs late disease 🔢 330 | 📅 2009

  • Imaging near metal with MAVRIC-SEMAC hybrid 🔢 313 | 📅 2011

  • Osteochondral lesions of the talus: MRI grading system 🔢 309 | 📅 2003

Youley Tjendra | Thyroid Cytopathology | Best Researcher Award

Published on by Global Academic Awards

Dr. Youley Tjendra | Thyroid Cytopathology | Best Researcher Award

Dr. Youley Tjendra, University of Miami Miller School of Medicine, United States

Based on the information provided, Youley Tjendra, M.D., appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

Strong Publication Record

Dr. Tjendra has an extensive list of peer-reviewed publications, including high-impact journal articles and book chapters. This indicates a significant contribution to the field of pathology and cytopathology.

Relevant Research Focus

His research covers a range of relevant topics within cytopathology, including diagnostic criteria, molecular testing, and innovative methods in cancer detection. This aligns well with the themes typically recognized by research awards

Diverse Experience

Dr. Tjendra has a diverse academic and clinical background, including fellowships and residencies in prestigious institutions. This breadth of experience is indicative of a well-rounded and accomplished researcher.

Recent and Ongoing Research

His recent and ongoing research, such as studies on the Milan System for reporting salivary gland cytopathology and TRPS1 expression in cancers, highlights his active engagement in cutting-edge research.

Academic and Clinical Integration

As a Clinical Instructor at the University of Miami, he integrates research with clinical practice, which can be a significant factor for awards that value practical impact.

Publication Top Notes

  • Exploring the atypia of undetermined significance: Malignant ratio, ThyroSeq v3 positive call rate, molecular-derived risk of malignancy, and risk of malignancy as possible quality metric tools in thyroid cytology (2024) 🦋 – 0 citations.
  • Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance (2024) 🦋 – 0 citations.
  • Utility of the Milan System for Reporting Salivary Gland Cytopathology in fine needle aspiration cytology of minor salivary gland lesions (2024) 💬 – 0 citations.
  • Don’t SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory (2024) 🧪 – 4 citations.
  • TRPS1 immunohistochemical expression in salivary gland tumors: A pilot study (2023) 🔬 – 4 citations.
  • Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV (2023) 🧬 – 3 citations.
  • Utility of TRPS1 in Malignant Effusion Cytology (2023) 🔬 – 4 citations.
  • A Triumvirate: Correlating Thyroid Cytopathology, Molecular Testing, and Histopathology (2023) 📚 – 1 citation.
  • Utility of high-risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid-based preparations from metastatic head and neck squamous cell carcinoma (2023) 🦠 – 4 citations.

Overall, Dr. Tjendra’s extensive publication record, relevant research focus, diverse experience, and ongoing contributions make him a suitable candidate for the Research for Best Researcher Award.